- Release Date: 20/06/25 09:21
- Summary: Appointment of new director and chair
- Price Sensitive: No
- Download Document 107.65KB
- Forums
- ASX - By Stock
- ACL
- Ann: Appointment of new director and chair
ACL
australian clinical labs limited
Add to My Watchlist
0.75%
!
$2.65

Ann: Appointment of new director and chair
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.65 |
Change
-0.020(0.75%) |
Mkt cap ! $524.3M |
Open | High | Low | Value | Volume |
$2.66 | $2.68 | $2.64 | $78.23K | 29.49K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 2848 | $2.64 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.66 | 6735 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 2846 | 2.640 |
7 | 11643 | 2.630 |
8 | 14062 | 2.620 |
9 | 44728 | 2.610 |
4 | 122298 | 2.600 |
Price($) | Vol. | No. |
---|---|---|
2.650 | 85 | 2 |
2.660 | 4139 | 8 |
2.670 | 10188 | 6 |
2.680 | 8687 | 5 |
2.690 | 38974 | 5 |
Last trade - 10.21am 03/09/2025 (20 minute delay) ? |
Featured News
ACL (ASX) Chart |
The Watchlist
FBM
FUTURE BATTERY MINERALS LIMITED
Nick Rathjen, Managing Director and CEO
Nick Rathjen
Managing Director and CEO
SPONSORED BY The Market Online